Intravenous adenosine echocardiography, a new pharmacologic stress test: Preliminary results and comparison with simultaneous thallium scintigraphy

Intravenous adenosine echocardiography, a new pharmacologic stress test: Preliminary results and comparison with simultaneous thallium scintigraphy

234A jACC Vol. 15, No. 2 February 1990234A ABSTRACTS ECHOCARDIOGRAPHY, NEW A AMIODARONE INDUCED RA Alan K Woclfel, .A.C sley, ?? . Universi...

262KB Sizes 0 Downloads 45 Views

234A

jACC Vol. 15, No. 2 February 1990234A

ABSTRACTS

ECHOCARDIOGRAPHY,

NEW

A

AMIODARONE INDUCED RA Alan K

Woclfel,

.A.C

sley,

?? .

University of NorthCarolina a!

inregard IOage,leflventicukuejection amiodaronc dasage(2&19vs 13&3 g

._. _. _

20 and SPECT versus angiography(n-42),using scar or respectively. Thus adenosine were 83% and 7 ischemia, stresstest that is 20 is a promisingnew pharmacologic comparable to adenosine SPECT in the detectionof CAD.

andti ETT(12&R vs 1Qt4days),QT

UTAMINE STRESSECROCARDIOORAI%~Y 8 CORREtATION DOSE PONSNENESS ANDQUANTITATIVE MIICGRAPHY da, ND,, Stephen E:.

Ryan,

William F.

dioine, Indianapolis,

IN

ry disease (CAD). The purpose of ate the dose of’Dobutamine and a regional wall motion abnormal-

) appeared with CADseverity.

Forty-four

aonaeoutive patients (pts) were identified who had a P s W

stenosis with &late

low dose of <20 mog/k&min resulted in 8 studiesbeingstopped prematurely. Of

ease (SVD). A new UHA at a

pts 7 had multivessel diaeasct (MfD) and 1 had a >7 proximal left anterior descending lesion. The new

ON OF IS FAMlOD

Antiarrhythmic agents acting on sodium channels do so in a use-dependent fashion which may be reversed by catacholamine administration.The purposeof this study was 10assess use-dependent effectsof chronicoral amiodarone(A) before and afteradministrationof isoproterenol(I). After oral amiodaroneloading (@am/day x 2weeks) dogs (n=4) underwent a baseline electrophysiologic study involving selective His-bundlepacing at paced cycle lengthsjust below the sinus rate to a maximal paced cycle length of 200msec. Isoproterenol was then infused at Sug/m.inuntil a stable sinus rate was achieved and the pacing protocol was repeated.The stimulus to ventricular electrogram interval (SV) for each pacedcycle length (CL) was comparedlo the SV of the longestpacedCL at baseline.Data a~ representedas themean% change(*SE) in SV as compared to the SV at the longest paced CL during the baseline study. CYCLELENGTH(msec) llfl

lesions and collaterals (al (all SVD) and 1 with a 75-90 (!JVD)- Of the pts with MIDmd no collaterala 22123 had a * DSB at a BR <125. We conclude that a +DSEat a lau dose or a flR
>I25 indleaka

mderate disease or collateral flow.

USE-DEPE

icheal C. Chin,BS Bertram G. Katzung, University of California,San Francisco.

ons supplied by vessels with >70

1 with luminal diameter 1.09 e 9 pta with a + DSEat a HR >125

NOL ON

17&3 23&3 23s

( *pa.01 #pa.05 )

27s

31f3 :!ti

35&3 38+2 14s 12&4

The mean serum amiodaronelevel was 2.Mo.8 mgldl. Conclusion: Isoproterenol significantly attenuates the use-dependent effect of chronically administered a~od~o~e in t canine model. These findings may help to explain how changes in neuro-humeraltone may alter clinical drug efficacy.